The United States has a patent on treating cancer with isolated forms of phytocannabinoids
According to a 2013 patent application the United States has an invention related to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS), as a prophylactic or in the therapeutic treatment of cancer.